An investigation of the functional significance of marginal riboflavin status in young wome
- Conditions
- Impaired handling of ironNutritional, Metabolic, EndocrineDisorders of mineral metabolism
- Registration Number
- ISRCTN35811298
- Lead Sponsor
- niversity of Sheffield (UK)
- Brief Summary
2009 protocol in https://www.ncbi.nlm.nih.gov/pubmed/19323801 2011 results in https://www.ncbi.nlm.nih.gov/pubmed/21525198
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 120
1. Women aged 19 to 25 years
2. Low milk consumption (less than 200 ml a day)
3. Healthy
4. Marginal riboflavin deficiency as measured by an Erythrocyte Glutathione Reductase Activation Coefficient of greater than 1.4; 1. Women aged 19 to 25 years
2. Low milk consumption (less than 200 ml a day)
3. Healthy
4. Marginal riboflavin deficiency as measured by an Erythrocyte Glutathione Reductase Activation Coefficient of greater than 1.4
1. Use of multivitamin or iron supplements (within last three months)
2. Diagnosed gastrointestinal disorders
2.1. coeliac disease
2.2. ulcerative colitis
2.3. Crohns disease
2.4. inflammatory bowel disease
3. Blood donors
4. Haemochromatosis
5. Pregnancy; 1. Use of multivitamin or iron supplements (within last three months)
2. Diagnosed gastrointestinal disorders
2.1. coeliac disease
2.2. ulcerative colitis
2.3. Crohns disease
2.4. inflammatory bowel disease
3. Blood donors
4. Haemochromatosis
5. Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method